Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2025
Reporting Period: Events occurring on March 28, 2025
Business Context: The Company is an emerging growth company incorporated in Texas, with its principal executive offices in Dallas. The filing reports unregistered sales of equity securities pursuant to Item 3.02.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction.
| Metric | Value |
|---|---|
| Total Series B Preferred Converted | 392 shares |
| Aggregate Stated Value of Preferred | $431,200 |
| Total Common Stock Issued | 287,467 shares |
| Conversion Price | $1.50 per share |
Material Changes
The material change reported is the conversion of Series B Convertible Preferred Stock into common stock by three separate holders on March 28, 2025. The specific transactions were:
- 260 shares of Series B Preferred ($286,000 stated value) converted into 190,667 shares of common stock.
- 74 shares of Series B Preferred ($81,400 stated value) converted into 54,267 shares of common stock.
- 58 shares of Series B Preferred ($63,800 stated value) converted into 42,533 shares of common stock.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. The Company claims an exemption from registration under Section 3(a)(9) of the Securities Act of 1933, as the securities were exchanged with existing holders without the payment of commissions or remuneration for solicitation.
Investor Verification Checklist
- Verify the total number of outstanding common shares post-conversion to assess dilution impact.
- Confirm the remaining balance of Series B Convertible Preferred Stock.
- Review the Company's cash position to ensure liquidity is sufficient given the lack of new capital raised in this transaction.
- Check for any subsequent filings regarding the impact of these conversions on the Company's capitalization table.